Darzalex Faspro
FDA Approves Darzalex Faspro With Bortezomib, Lenalidomide and Dexamethasone for Multiple Myeloma
The FDA has approved Darzalex Faspro in combination with bortezomib, lenalidomide and dexamethasone for induction ...
JULY 31, 2024
FDA Approves Darzalex Faspro With Pom-Dex for Multiple Myeloma
The FDA approved daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen) in combination with pomalidomide and ...
JULY 15, 2021
Load more